Today: 25 December 2025
Subscribe
Browse Category

Legal Updates News 9 November 2025 - 27 November 2025

Archer Aviation (ACHR) Stock Today, November 22, 2025: Price Action, PNC Buying, Joby Lawsuit and Short Report Explained

Archer Aviation (ACHR) Stock Today, November 22, 2025: Price Action, PNC Buying, Joby Lawsuit and Short Report Explained

Archer Aviation (NYSE: ACHR) heads into the weekend at the center of one of the hottest storylines in the emerging electric air‑taxi (eVTOL) sector: a bruised share price, a fresh institutional buyer, an aggressive short‑seller report, and a high‑stakes lawsuit
23 November 2025
 ·  ·  ·  · 
Meta Platforms (META) November 2025 Stock Analysis: AI-Fueled Growth vs. Rising Costs

Meta (META) Stock Today — Nov. 17, 2025: Red Sea Cable Delays, Renewable-Energy Milestone, and a Pixel Lawsuit Settlement

Published Nov. 17, 2025 Quick take: Meta Platforms (NASDAQ: META) traded modestly lower on Monday as investors weighed fresh infrastructure and legal headlines against a calm-but-cautious broader market tone ahead of key U.S. data and Nvidia earnings later this week.
17 November 2025
 ·  ·  ·  ·  · 
Alibaba Stock Soars on AI Frenzy – Can the Rally Last?

Alibaba (BABA) sinks ~3.8% at the close after White House memo allegations; France flags AliExpress; class‑action probe announced — Nov. 14, 2025

Alibaba’s U.S.-listed shares finished Friday sharply lower after fresh geopolitical and regulatory headlines weighed on sentiment into the bell. Key takeaways (Nov. 14, 2025, after market close, ~4:00 p.m. ET) What moved Alibaba stock today White House memo report and
14 November 2025
 ·  ·  ·  ·  · 
Bristol‑Myers Squibb (BMY) today: €5B euro‑notes closing, $239M Celgene suit settlement, BioNTech cash flows lift guidance — what to watch on November 9, 2025

Bristol‑Myers Squibb (BMY) today: €5B euro‑notes closing, $239M Celgene suit settlement, BioNTech cash flows lift guidance — what to watch on November 9, 2025

Financing & balance sheet: euro notes + tender offer Bristol‑Myers Squibb priced €5 billion in senior unsecured notes across five tranches — €750M 2030 (2.973%), €1.15B 2033 (3.363%), €1.15B 2038 (3.857%), €750M 2045 (4.289%), and €1.2B 2055 (4.581%) — with
9 November 2025
 ·  ·  ·  ·  ·  · 
J&J Makes Bold Move: Orthopedics Spin-Off (“DePuy Synthes”) Announced – 2025 Forecast Raised

NJ Stock: What to Know Before the Bell on November 10, 2025 (Fresh FDA Wins, Dividend Date, and Legal Overhang)

Dateline: Monday, November 10, 2025 — pre‑market Johnson & Johnson (NYSE: JNJ) starts the new week with momentum from multiple drug approvals, a firm dividend timetable, and a still‑active litigation backdrop. Here’s a concise, investor‑focused briefing on the key developments
9 November 2025
 ·  ·  ·  ·  ·  ·  · 
1 2 3 4
Go toTop